相关实验视频
Updated: Jan 13, 2026

04:48
Control of Eating Behavior Using a Novel Feedback System
Published on: May 8, 2018
11.5K
胃口调节和全静电负荷跨越糖尿病前的表型
Steven K Malin1,2,3,4, Emily M Heiston1
1Department of Kinesiology & Health, Rutgers University, New Brunswick, NJ 08901, USA.
Nutrients
|January 10, 2026
概括
慢性压力,以全静电负荷来衡量,影响糖尿病前期患者的食欲调节. 患有快食葡萄糖受损和葡萄糖耐受性受损的个体表现出更高的全静电负荷和改变的 ghrelin 水平.
科学领域:
- 内分泌学 在内分泌学.
- 代谢健康 代谢健康
- 压力生理学 压力生理学
背景情况:
- 静态负荷量化慢性压力,这是一个涉及食欲失调的因素.
- 患有肥胖和2型糖尿病的个体表现出较高的全静电负荷.
- 静态负荷,糖尿病前表型和食欲之间的关系尚不清楚.
研究的目的:
- 为了研究糖尿病前期表型之间全静电负荷的差异.
- 检查在糖尿病前期的全静电负荷和食欲调节之间的关联.
主要方法:
- 一项涉及肥胖个体的横截面研究.
- 使用美国糖尿病协会 (ADA) 标准 (75 g OGTT) 进行前糖尿病分类.
- 在OGTT期间测量食欲激素 (格林,PYY),葡萄糖,胰岛素和主观食欲评级.
- 从生理标志物计算静态负荷;评估有氧健身,身体组成和临床实验室.
主要成果:
- 与IFG或IGT单独相比,联合患有禁食葡萄糖 (IFG) 损伤和葡萄糖耐受性损伤 (IGT) 的个体表现出更高的全静态负荷,肥胖和胰岛素耐药性 (p <0.05).
- 与其他组相比,IFG + IGT组表现出较低的禁食格林水平,但与其他组相比具有相似的禁食PYY水平.
- 虽然饥饿和腹感知是可比的,但IFG + IGT组中脂肪食物的评级往往更高.
结论:
- 在IFG+IGT组中,更高的全静电负荷与改变的禁食格林,体重增加和胰岛素抵抗有关.
- 这些发现表明,慢性压力可能是各种形式的糖尿病前期的食欲调节障碍的一个因素.
相关概念视频
Regulation of Food Intake
2.3K
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
2.3K
Diabetes: Symptoms, Diagnosis, and Complications
2.0K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.0K
Carbohydrate Metabolism
13.8K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.8K
Glucose Homeostasis: Regulation of Blood Glucose
3.8K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
3.8K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
235
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
235
Insulin: Dosing Regimen and Adverse Effects
673
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
673

